
Results
3
Companies which are more than 50% undervalued based on analyst price target.
3 companies
Photocure
Market Cap: NOK 1.4b
Engages in the research, development, production, distribution, marketing, and sale of pharmaceutical products.
PHO
NOK 51.40
7D
-3.6%
1Y
-14.8%
Nykode Therapeutics
Market Cap: NOK 1.0b
A clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies for the treatment of cancer and autoimmune diseases.
NYKD
NOK 3.22
7D
-8.5%
1Y
90.6%
Lytix Biopharma
Market Cap: NOK 653.7m
A clinical stage biotech company, develops novel cancer immunotherapies for cancer therapy in the United States.
LYTIX
NOK 8.40
7D
-4.1%
1Y
-5.2%